Akros Korea Shareholder Return High Dividend Index
Concentrated exposure to the top 30 financially robust Korean companies maximizing total shareholder return through dividends and share buybacks.
Sentiment Summary
Recent Events
Daishin Securities is scheduled to release its Q1 2026 earnings on May 19, 2026, expected.
Poongsan is scheduled to announce its Q1 2026 earnings results on May 18, 2026. Analysts forecast a record-high performance due to rising copper prices, with sales of KRW 1.1 trillion and operating profit of KRW 74.4 billion estimated.
Q1 2026 earnings release scheduled; analysts forecast strong results, leading to a stock price surge on April 1, 2026, estimated.
Q1 2026 earnings release on 2026-05-18 is a routine announcement and is scheduled.
Q1 2026 earnings release is scheduled.
Q1 2026 earnings release scheduled.
LG Uplus is scheduled to announce its Q1 2026 earnings results on May 7, 2026, as forecasted by financial data providers. Analysts expect strong performance relative to competitors scheduled.
Q1 2026 earnings release on 2026-05-07, with an estimated medium impact (>=5%) as investors monitor growth sustainability, is scheduled.
Q1 2026 earnings release scheduled on April 28, 2026; analysts forecast revenue of 1.947 trillion KRW. Medium importance is estimated based on typical earnings volatility scheduled.
Q1 2026 earnings release scheduled for April 25, 2026. Analysts forecast a YoY increase in net profit, though estimates vary. Estimated price impact: ≥5% as earnings are a key driver, forecasted.
Kia is scheduled to announce its Q1 2026 earnings results on April 24, 2026; a medium price impact (>=5%) is anticipated based on historical earnings volatility, scheduled.
Q1 2026 earnings release conference call scheduled for April 24, 2026; analysts forecast sluggish performance due to one-off costs and increased investments. Medium importance is estimated.
Woori Financial Group is scheduled to announce its earnings results for the first quarter of 2026 on 2026-04-24. Analysts forecast a significant increase in net profit compared to the same period last year, estimated to be around KRW 774.1 billion to KRW 901.0 billion. This is expected to have a medium impact as significant profit growth typically influences stock prices by approximately 5%, scheduled.
Q1 2026 earnings release scheduled for April 24, 2026; analysts forecast a record Q1 operating profit of over KRW 322 billion. Market impact estimated at >=1% due to record profit expectations forecasted.
Q1 2026 earnings release scheduled. Analysts forecast a significant year-over-year increase in net profit, potentially reaching a record high. A >=5% price impact is estimated as it confirms the growth trajectory, scheduled.
Payment date on 2026-04-17 for the fiscal year 2025 annual dividend of KRW 5,300 per share (ex-dividend date December 29, 2025) with an estimated 5% price impact from the dividend yield scheduled.
Kolon Industries Inc. was the surviving entity in its merger with Kolon ENP; merger shares for Kolon Industries were scheduled to be listed on 2026-04-16, and Kolon ENP was delisted on 2026-04-16 due to dissolution following the merger.
Celltrion announced significant market share expansion in major European countries for its key products, including winning major tenders in France and achieving top market share for several drugs in Germany.
Kiwoom Securities lowered its target price to KRW 22,000 from KRW 24,000, forecasting an annual sales loss of up to KRW 29 billion due to hotel renovations and increased costs, which are expected to negatively impact Q1 2026 operating profit, as reported on April 15, 2026. The medium importance is based on the significant target price reduction and projected revenue loss, forecasted.
On April 15, 2026, the company announced the cancellation of a planned KRW 42 billion acquisition of a beneficial certificate from its affiliate, Daishin Asset Management, as the underlying fund was not established.
Announced the opening of logistics centers in Los Angeles and Savannah on April 15, 2026; due to infrastructure expansion, a 1% price impact is scheduled.
Announced the signing of a long-term charter contract for an additional VLCC on April 15, 2026; due to fleet expansion, a 1% price impact is scheduled.
Analysts forecast on April 15, 2026, that Q1 2026 operating profit will be KRW 271.5 billion (-18.5% YoY) and the Bio division will bottom out, forecasted.
NH Investment & Securities analysts upgraded their rating on the company to 'Buy' from 'Hold' on April 14, 2026, citing that the stock price had fallen excessively despite solid earnings.
SK Securities and Hana Securities analysts forecast Q1 2026 net profits of approximately ₩403.5B and ₩411.1B, respectively. A >=1% price impact is estimated due to market expectation setting, forecasted.
Celltrion announced the completion of its largest-ever treasury stock cancellation, retiring 9.11 million shares (approx. 3.94% of total shares) valued at around 1.78 trillion KRW, effective April 13, 2026.
Analysts at Meritz Securities and Hanwha Investment & Securities forecast strong Q1 2026 results on 2026-04-13, expecting double-digit growth in revenue and operating profit, driven by strong overseas performance, particularly in Malaysia and Thailand. This forecast is expected to have a medium impact as it signals continued growth momentum, forecasted